Important Announcement

X

ChemIDplus is moving to PubChem in December 2022.
Please see the NLM Technical Bulletin article for more information.

Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Maltose [JAN:NF]
RN: 69-79-4
UNII: 66Y63L379N
InChIKey: DKXNBNKWCZZMJT-WUJBLJFYSA-N

Note

  • A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. (Grant & Hackh's Chemical Dictionary, 5th ed).

Molecular Formula

  • C12-H22-O11

Molecular Weight

  • 342.2965
 

Classification Codes

  • Drug / Therapeutic Agent
  • Flavoring Agents
  • Food Additives
  • Human Data
  • Natural Product
  • Reproductive Effect
  • Sweetening Agents
  • Tumor Data
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • 4-O-alpha-D-Glucopyranosyl-D-glucose
  • D-Glucose, 4-O-alpha-D-glucopyranosyl-
  • Maltose
  • Maltose [JAN:NF]

MeSH Heading

  • Maltose

Synonyms

  • 4-(alpha-D-Glucopyranosido)-alpha-glucopyranose
  • 4-(alpha-D-Glucosido)-D-glucose
  • 4-O-alpha-D-Glucopyranosyl-beta-D-glucopyranose
  • 4-O-alpha-D-Glucopyranosyl-D-glucose
  • 5-17-07-00189 (Beilstein Handbook Reference)
  • Advanctose 100
  • AI3-09089
  • BRN 0093798
  • Cextromaltose
  • D-(+)-Maltose
  • D-Maltose
  • EINECS 200-716-5
  • Finetose
  • Finetose F
  • Malt sugar
  • Maltobiose
  • Maltodiose
  • Maltose
  • NSC 760396
  • Sunmalt
  • Sunmalt S
  • UNII-66Y63L379N

Systematic Names

  • 4-O-alpha-D-Glucopyranosyl-D-glucose
  • D-Glucose, 4-O-alpha-D-glucopyranosyl-
  • Maltose
  • Maltose, pure

Superlist Names

  • D-Glucose, 4-O-alpha-D-glucopyranosyl-
  • Maltose

Registry Numbers

CAS Registry Number

  • 69-79-4

FDA UNII

  • 66Y63L379N

Other Registry Numbers

  • 1083048-13-8
  • 47297-42-7
  • 73824-72-3
  • 77072-48-1

System Generated Number

  • 0000069794

Structure Descriptors

InChI

1S/C12H22O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h1,4-12,14-21H,2-3H2/t4-,5+,6+,7+,8+,9-,10+,11+,12+/m0/s1

InChIKey

DKXNBNKWCZZMJT-WUJBLJFYSA-N

Smiles

OC[C@@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 29100mg/kg (29100mg/kg)   Drugs in Japan Vol. -, Pg. 1139, 1990.
mouse LD50 intravenous 26800mg/kg (26800mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 7, Pg. 53, 1979.
mouse LD50 oral > 44gm/kg (44000mg/kg)   Drugs in Japan Vol. -, Pg. 1139, 1990.
mouse LD50 subcutaneous 38600mg/kg (38600mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 7, Pg. 53, 1979.
rabbit LD50 intravenous 25200mg/kg (25200mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 541, 1972.
rat LD subcutaneous > 26700mg/kg (26700mg/kg) BEHAVIORAL: EXCITEMENT Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 251, 1972.
rat LD50 intraperitoneal 30600mg/kg (30600mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 251, 1972.
rat LD50 intravenous 15300mg/kg (15300mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 251, 1972.
rat LD50 oral 34800mg/kg (34800mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 7, Pg. 53, 1979.
women TDLo oral 100mg/kg/2D-I (100mg/kg)   Annals of Internal Medicine. Vol. 118, Pg. 526, 1993.
women TDLo oral 100mg/kg/2D-I (100mg/kg) BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" Annals of Internal Medicine. Vol. 118, Pg. 526, 1993.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 102-103 deg C   EXP
log P (octanol-water) -5.030 (none)   EST
Water Solubility 7.80E+05 mg/L 20 EXP
Vapor Pressure 8.09E-17 mm Hg 25 EST
Henry's Law Constant 3.40E-19 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 1.54E-10 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.